• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B.

作者信息

Huang Chiuan-Bo, Su Tung-Hung, Kao Jia-Horng

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Liver Int. 2023 Apr;43(4):947-948. doi: 10.1111/liv.15536. Epub 2023 Feb 17.

DOI:10.1111/liv.15536
PMID:36732913
Abstract
摘要

相似文献

1
Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B.抗-HBc水平预测慢性乙型肝炎患者停用核苷（酸）类似物后的病毒学复发
Liver Int. 2023 Apr;43(4):947-948. doi: 10.1111/liv.15536. Epub 2023 Feb 17.
2
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.停止 HBeAg 阴性慢性乙型肝炎核苷（酸）类似物治疗后乙型肝炎病毒特异性 T 细胞应答。
J Hepatol. 2018 Sep;69(3):584-593. doi: 10.1016/j.jhep.2018.05.004. Epub 2018 Jun 29.
3
Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy.血清乙型肝炎核心蛋白抗体水平与核苷（酸）类似物治疗停药后临床复发相关。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):182-191.e1. doi: 10.1016/j.cgh.2018.05.047. Epub 2018 Jun 11.
4
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.在 HBeAg 血清学转换后停止使用核苷（酸）类似物治疗的高加索乙型肝炎患者，复发率高，结局致命。
Aliment Pharmacol Ther. 2018 Apr;47(8):1170-1180. doi: 10.1111/apt.14560. Epub 2018 Mar 2.
5
Severity of Hepatitis B Relapse After Cessation of Nucleos(t)ide Analog: Need a Closer Look!核苷（酸）类似物停药后乙型肝炎复发的严重程度：需要进一步研究！
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1885-1886. doi: 10.1016/j.cgh.2021.09.004. Epub 2021 Sep 9.
6
Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.乙型肝炎病毒 RNA 与乙型肝炎核心相关抗原联合检测：乙型肝炎 e 抗原阳性慢性乙型肝炎患者安全停用核苷（酸）类似物的指导意见。
J Infect Dis. 2020 Jul 23;222(4):611-618. doi: 10.1093/infdis/jiaa136.
7
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.聚乙二醇干扰素 α-2a 联合核苷（酸）类似物治疗与单独核苷（酸）类似物治疗对 HBeAg 阴性慢性乙型肝炎患者持续不可检测的血浆乙型肝炎病毒 DNA 的影响：一项随机、对照、开放标签试验。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):177-188. doi: 10.1016/S2468-1253(16)30189-3. Epub 2017 Jan 20.
8
A comment on "A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B".关于“一项关于HBeAg阴性慢性乙型肝炎核苷（酸）类似物停药的多中心随机对照试验”的评论
J Hepatol. 2024 May;80(5):e229-e230. doi: 10.1016/j.jhep.2023.07.038. Epub 2023 Aug 11.
9
Reply to: "A comment on `A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B'".回复：“对‘一项关于HBeAg阴性慢性乙型肝炎核苷（酸）类似物停药的多中心随机对照试验’的评论”
J Hepatol. 2024 May;80(5):e230-e231. doi: 10.1016/j.jhep.2023.11.034. Epub 2023 Dec 16.
10
Reply to the letter "Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B".对信件《抗-HBc水平预测慢性乙型肝炎患者停用核苷（酸）类似物后的病毒学复发》的回复
Liver Int. 2023 Apr;43(4):949. doi: 10.1111/liv.15551. Epub 2023 Mar 8.